{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:00:20Z","timestamp":1790827220552,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.parint.2009.07.008","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T08:11:04Z","timestamp":1248682264000},"page":"359-366","source":"Crossref","is-referenced-by-count":26,"title":["Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"58","author":[{"given":"Rajeev","family":"Nagill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2009.07.008_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/pgmj.2006.047340corr1","article-title":"Leishmaniasis","volume":"83","author":"Piscopo","year":"2006","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.parint.2009.07.008_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10\u00a0years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.parint.2009.07.008_bib3","unstructured":"World Health Organization\u2014TDR. The TDR fifteenth programme report. Research progress 1999\u20132000. New and improved tools. 2003; www.who.int\/tdr\/research\/progress9900\/tools\/vdr.htm."},{"issue":"3","key":"10.1016\/j.parint.2009.07.008_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0738-081X(99)00050-4","article-title":"Global control and Leishmania HIV co-infection","volume":"17","author":"Desjeux","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.parint.2009.07.008_bib5","unstructured":"Dumonteil E, McMahon-Pratt D, Price VL. Report of the fourth TDR\/IDRI meeting on second generation vaccines against leishmaniaisis. UNDP\/EWorld Bank\/WHO Special Programme for Research & Training in Tropical Diseases (TDR). 2001;TDR\/PRD\/Leish\/Vac\/01.1."},{"issue":"9\u201310","key":"10.1016\/j.parint.2009.07.008_bib6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.parint.2009.07.008_bib7","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Gonc\u00b8alo do Amarante RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"19\u201320","key":"10.1016\/j.parint.2009.07.008_bib8","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"29\u201330","key":"10.1016\/j.parint.2009.07.008_bib9","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2004.03.058","article-title":"Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district I.R. Iran","volume":"22","author":"Mohebali","year":"2004","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.parint.2009.07.008_bib10","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.parint.2009.07.008_bib11","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune\u00ae vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.parint.2009.07.008_bib12","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.parint.2009.07.008_bib13","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune\u00ae) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.parint.2009.07.008_bib14","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomized efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.parint.2009.07.008_bib15","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","article-title":"Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune\u00ae vaccine","volume":"25","author":"Santos","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.parint.2009.07.008_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/infdis\/172.4.1055","article-title":"Identification of Leishmania chagasi antigens recognized by human lymphocytes","volume":"172","author":"Jeronimo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.parint.2009.07.008_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/1566524043360212","article-title":"Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis","volume":"4","author":"Ravindran","year":"2004","journal-title":"Curr Mol Med"},{"issue":"6","key":"10.1016\/j.parint.2009.07.008_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0074-02761996000600006","article-title":"Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs","volume":"91","author":"Mayrink","year":"1996","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.parint.2009.07.008_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182097002175","article-title":"Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG","volume":"116","author":"Dube","year":"1998","journal-title":"Parasitology"},{"issue":"1","key":"10.1016\/j.parint.2009.07.008_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.69.1.245-251.2001","article-title":"Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection","volume":"69","author":"Gicheru","year":"2001","journal-title":"Infect Immun"},{"issue":"25\u201326","key":"10.1016\/j.parint.2009.07.008_bib21","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(01)00058-5","article-title":"Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania with BCG","volume":"19","author":"Misra","year":"2001","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.parint.2009.07.008_bib22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1590\/S0074-02762002000700019","article-title":"Study of the safety, immunogenicity and efficacy of autoclaved and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease","volume":"97","author":"Amaral","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.parint.2009.07.008_bib23","first-page":"159","article-title":"The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis","volume":"36","author":"Michel","year":"2006","journal-title":"J Egypt Soc Parasitol"},{"key":"10.1016\/j.parint.2009.07.008_bib24","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.parint.2009.07.008_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.rvsc.2007.09.008","article-title":"Antigenicity of whole parasite vaccine as promising candidate against canine leishmaniasis","volume":"85","author":"Giunchetti","year":"2008","journal-title":"Res Vet Sci"},{"issue":"2","key":"10.1016\/j.parint.2009.07.008_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0031182003003457","article-title":"Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis","volume":"127","author":"Srivastava","year":"2003","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.parint.2009.07.008_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/00034983.1985.11811917","article-title":"An experimental vaccine against American dermal leishmaniasis: experience in the state of Espirito Santo, Brazil","volume":"79","author":"Mayrink","year":"1985","journal-title":"Ann Trop Med Parasitol"},{"issue":"11","key":"10.1016\/j.parint.2009.07.008_bib28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0264-410X(94)90342-5","article-title":"Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG I. Skin-test reactivity T-cell proliferation and interferon-\u03b3 production","volume":"12","author":"Castes","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.parint.2009.07.008_bib29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/515265","article-title":"Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population. Safety, immunogenicity, and efficacy during the first 12\u00a0months of follow-up","volume":"177","author":"Armijos","year":"1998","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.parint.2009.07.008_bib30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","article-title":"A randomised, double-blind controlled trial of a killed Leishmania major plus BCG against zoonotic cutaneous leishmaniasis in Iran","volume":"17","author":"Momeni","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.parint.2009.07.008_bib31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomized, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"issue":"9115","key":"10.1016\/j.parint.2009.07.008_bib32","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic leishmaniasis in Bam, Iran","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"issue":"15\u201316","key":"10.1016\/j.parint.2009.07.008_bib33","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0264-410X(00)00401-1","article-title":"Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers","volume":"19","author":"Satti","year":"2001","journal-title":"Vaccine"},{"issue":"8530","key":"10.1016\/j.parint.2009.07.008_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(87)90116-4","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"1","author":"Convit","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.parint.2009.07.008_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-3024.2000.00278.x","article-title":"Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients","volume":"22","author":"Cabrera","year":"2000","journal-title":"Parasite Immunol"},{"issue":"4","key":"10.1016\/j.parint.2009.07.008_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0035-9203(03)90093-9","article-title":"Immunotherapy of American cutaneous leishmaniasis in Venezuela during the period 1990\u201399","volume":"97","author":"Convit","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.parint.2009.07.008_bib37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1086\/375399","article-title":"Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: how long does protection last?","volume":"187","author":"Armijos","year":"2003","journal-title":"J Infect Dis"},{"issue":"52","key":"10.1016\/j.parint.2009.07.008_bib38","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.parint.2009.07.008_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0074-02762004000100010","article-title":"Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report","volume":"99","author":"Convit","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.parint.2009.07.008_bib40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vaccine.2007.11.057","article-title":"A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs","volume":"26","author":"Giunchetti","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.parint.2009.07.008_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s004360050501","article-title":"Strain-specific recognition of live Leishmania donovani promastigotes by homologous antiserum raised against a crude membrane fraction of infected macrophages","volume":"85","author":"Goel","year":"1999","journal-title":"Parasitol Res"},{"key":"10.1016\/j.parint.2009.07.008_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.parint.2009.07.008_bib43","first-page":"119","article-title":"Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice","volume":"30","author":"Bradley","year":"1977","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.parint.2009.07.008_bib44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00436-008-1150-x","article-title":"Effect of dose and route of inoculation on the generation of CD4+ Th1\/Th2 type of immune response in murine visceral leishmaniasis","volume":"103","author":"Kaur","year":"2008","journal-title":"Parasitol Res"},{"issue":"5","key":"10.1016\/j.parint.2009.07.008_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/icb.1987.44","article-title":"Heterologous protection in murine cutaneous leishmaniasis","volume":"65","author":"Mitchell","year":"1987","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.parint.2009.07.008_bib46","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4049\/jimmunol.150.6.2322","article-title":"Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis","volume":"150","author":"Nurit","year":"1993","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.parint.2009.07.008_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/expr.1996.4117","article-title":"Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease","volume":"85","author":"Gicheru","year":"1997","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.parint.2009.07.008_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-9292-6-7","article-title":"Consultation meeting on the development of therapeutic vaccines for post kala-azar dermal leishmaniasis","volume":"6","author":"Ghalib","year":"2007","journal-title":"Kinetoplastid Biol Dis"},{"issue":"1","key":"10.1016\/j.parint.2009.07.008_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trstmh.2007.08.006","article-title":"Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment","volume":"102","author":"Musa","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.parint.2009.07.008_bib50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/IAI.66.1.18-27.1998","article-title":"Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani","volume":"66","author":"Melby","year":"1998","journal-title":"Infect Immun"},{"issue":"5069","key":"10.1016\/j.parint.2009.07.008_bib51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1636090","article-title":"Establishment of cell-mediated immunity that makes \u201csusceptible\u201d mice resistant to Leishmania major","volume":"257","author":"Bretscher","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.parint.2009.07.008_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0001-706X(99)00007-8","article-title":"Leishmania donovani: cellular and humoral immune responses in Indian langur monkeys Presbytus entellus","volume":"73","author":"Dube","year":"1999","journal-title":"Acta Trop"},{"issue":"6","key":"10.1016\/j.parint.2009.07.008_bib53","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1172\/JCI112209","article-title":"Absence of gamma-interferon and interleukin-2 production during active visceral leishmaniasis","volume":"76","author":"Carvalho","year":"1985","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.parint.2009.07.008_bib54","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","article-title":"Restoration of IFN-\u03b3 production and lymphocyte proliferation in visceral leishmaniasis","volume":"152","author":"Carvalho","year":"1994","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.parint.2009.07.008_bib55","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.143.12.4244","article-title":"Experimental visceral leishmaniasis: role of endogenous IFN-\u03b3 in host defense and tissue granulomatous response","volume":"143","author":"Squires","year":"1989","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.parint.2009.07.008_bib56","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/IAI.62.3.1058-1063.1994","article-title":"Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis","volume":"62","author":"Miralles","year":"1994","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.parint.2009.07.008_bib57","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/516482","article-title":"Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis","volume":"175","author":"Murray","year":"1997","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.parint.2009.07.008_bib58","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"Stober","year":"2005","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.parint.2009.07.008_bib59","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1128\/IAI.73.11.7620-7628.2005","article-title":"Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection","volume":"73","author":"Roberts","year":"2005","journal-title":"Infect Immun"}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576909000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576909000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T04:24:46Z","timestamp":1685075086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576909000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1383576909000944"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2009.07.008","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}